(Reuters) - GlaxoSmithKline GSK.L said on Thursday it agreed to sell its entire stake in Unilever's ULVR.L Indian business HLL.NS for about 254.8 billion rupees ($3.35 billion) on the open market, cashing in late from the sale of the Horlicks brand. (reut.rs/3fvie8r)
Reporting by Pushkala Aripaka in Bengaluru; Editing by Anil D’Silva
Our Standards: The Thomson Reuters Trust Principles.